C. Giannini et al., Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading, J NE EXP NE, 60(3), 2001, pp. 248-262
Citations number
25
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Prognostic value of histological grading of oligodendroglial tumors is cont
roversial and interobserver reproducibility in grading of these tumors is u
nknown. Seven neuropathologists and 6 surgical pathologists experienced in
brain tumor diagnosis assessed 124 oligodendroglial tumors operated at the
Mayo Clinic (1960-1990). Among histologic parameters upon which current oli
godendroglioma grading systems are based, only high cellularity, presence o
f mitoses, microcalcifications, endothelial hypertrophy, endothelial prolif
eration, and necrosis appeared to be reproducible. Reproducible histologic
features, based on consensus ratings among neuropathologists (defined as >6
0%), were evaluated for the association with cause-specific survival by fit
ting Cox regression models. By univariate analysis, a significant associati
on with survival was found for age, high cellularity, presence of mitoses,
endothelial hypertrophy and proliferation and necrosis. On multivariable an
alysis with a stepwise variable selection method, only age and presence of
endothelial proliferation were found to be independently associated with su
rvival with a discriminatory index of the model of 0.68. Mitotic index was
significantly associated with survival based on the grading from each separ
ate neuropathologist, but it was not based on consensus, most likely becaus
e this was classified as indeterminate in 54% of cases. Alternatively, "mod
els fit" considering the assessment of single neuropathologists, identified
a model based on age and on mitotic index with similar discriminatory indi
ces of 0.69-0.7. Our study found few factors independently associated with
cause specific-survival among morphological parameters. These findings are
consistent with the present WHO stratification of oligodendrogliomas into l
ow- and high-grade variants.